Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TROFOSFAMIDE for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 13 adverse event reports in the FDA FAERS database where TROFOSFAMIDE was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for TROFOSFAMIDE

Side Effect Reports % Deaths Hosp.
Acute myeloid leukaemia 18 16.5% 9 1
Myelodysplastic syndrome 18 16.5% 9 1
Product use in unapproved indication 16 14.7% 0 2
Off label use 15 13.8% 2 1
Neutropenia 14 12.8% 1 6
Anaemia 13 11.9% 0 0
Dyspnoea 12 11.0% 0 7
Oedema 10 9.2% 0 0
Pleural effusion 10 9.2% 0 5
Hepatosplenomegaly 9 8.3% 0 0
Hyperleukocytosis 9 8.3% 1 0
Rhabdomyosarcoma recurrent 9 8.3% 2 0
Thrombocytopenia 9 8.3% 0 0
Neoplasm progression 8 7.3% 2 0
Acute kidney injury 7 6.4% 1 5

Other Indications for TROFOSFAMIDE

Metastatic malignant melanoma (32) Alveolar rhabdomyosarcoma (12) Langerhans' cell histiocytosis (11) Angioimmunoblastic t-cell lymphoma (6) Product used for unknown indication (6) Hodgkin's disease (5) Lymphoma (5)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

TROFOSFAMIDE Full Profile All Diffuse large b-cell lymphoma Drugs TROFOSFAMIDE Demographics TROFOSFAMIDE Timeline